GGO Vergunningendatabase

Zoekcriteria
Zoekresultaat
IM-MV 24-001_000 Amsterdam UMC Local oncolytic adenovirus administration to sensitize the immune microenvironment of esophageal adenocarcinoma for chemoradiation 07-06-2024 Vergunning verleend
IM-MV 24-002_000 Universitair Medisch Centrum Utrecht Two clinical studies (Trials 1504-0001 and 1504-0003) with BI 3720931, a replication-deficient, self-inactivating, 3rd generation lentiviral vector gene therapy developed for inhaled treatment of cystic fibrosis 11-07-2024 Ontwerpbesluit genomen